We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 45.50 | 44.60 | 46.00 | 0.00 | 08:00:06 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -14.54 | 336.41M |
From Apr 2019 to Apr 2024
TIDMBMK
RNS Number : 3591Q
Benchmark Holdings PLC
29 November 2016
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Capital Markets Day
Benchmark Holdings, the aquaculture biotechnology and food chain sustainability business, announces that it will be holding its first Capital Markets Day for analysts and institutional investors today in London at 1 PM.
No new material information will be disclosed, and all presentation materials will be made available on the Company's website (www.benchmarkplc.com) shortly after the event.
-Ends-
Hot Features
Premium
For further information,
please contact:
Benchmark Holdings plc Tel: 020 7920 3150
Malcolm Pye, CEO
Roland Bonney, COO
Rachel Aninakwah, Communications
Numis Tel: 020 7260 1000
Michael Meade / Freddie Barnfield
(NOMAD)
James Black (Corporate Broking)
Tavistock Tel: 020 7920 3150
Matt Ridsdale / Niall Walsh
Notes to Editors:
Founded in 2000, Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.
The company has proven distribution capabilities in high growth markets and through these it provides world leading: Products - through an integrated package of high genetic merit breeding stock, next era vaccines, pharmaceuticals and biocides and advanced nutrition diets for the early stages of production; Manufacturing - delivering cutting-edge technologies in animal health vaccines, aquaculture breeding production facilities /technology and state-of-the-art advanced nutrition product manufacturing; Services - from veterinary clinical and diagnostic to technical in field/on farm support and genetic programme management; Knowledge - through consultancy, professional training, technical online & book publishing and data management systems; Research - into major health and management challenges facing aquaculture, agriculture and animal health care informing the development of the group's medicines, vaccines and management technologies.
Benchmark operates internationally with offices in England, Scotland, Belgium, Ireland, Norway, Iceland, USA, Brazil, China, Russia, Portugal, Thailand and Chile. As at 30 September 2016, Benchmark employed 891 people.
For further information on Benchmark please visit www.benchmarkplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGMMZMLRZGVZM
(END) Dow Jones Newswires
November 29, 2016 02:00 ET (07:00 GMT)
1 Year Benchmark Chart |
1 Month Benchmark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
